Octagon Capital Advisors’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $35.7M | Sell |
|
|||||
|
2023
Q3 | $35.3M | Hold |
|
|||||
|
2023
Q2 | $40M | Sell |
|
|||||
|
2023
Q1 | $39.6M | Sell |
|
|||||
|
2022
Q4 | $51.3M | Sell |
|
|||||
|
2022
Q3 | $69.8M | Sell |
|
|||||
|
2022
Q2 | $67.7M | Buy |
|
|||||
|
2022
Q1 | $78.6M | Buy |
|
|||||
|
2021
Q4 | $84.8M | Buy |
|
|||||
|
2021
Q3 | $33.8M | Buy |
|
|||||
|
2021
Q2 | $20.9M | Buy |
|
|||||
|
2021
Q1 | $11.2M | Buy |
|
|||||
|
2020
Q4 | $7.79M | Buy |
|